Back
Capricor Therapeutics Vs. Sarepta Therapeutics Industry Stock Comparison
Buy
73
CAPR
Capricor Therapeutics
Last Price:
6.22
Seasonality Move:
8.34%
Sell
48
SRPT
Sarepta Therapeutics
Last Price:
131.39
Seasonality Move:
8.89%
Buy
73
Capricor Therapeutics (CAPR)
is a Buy
Is Capricor Therapeutics a Buy, Sell or Hold?
- The current Capricor Therapeutics [CAPR] share price is $6.20. The Score for CAPR is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
- CAPR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
48
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $131.38. The Score for SRPT is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CAPR Stock Price Chart
What is Capricor Therapeutics's stock price today?
-
The Capricor Therapeutics share price today is $6.20
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CAPR is experiencing slight buying pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $131.38
The current trend is moderately bullish and SRPT is experiencing slight buying pressure.
CAPR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 63.72 | Buy |
| Chaikin Money Flow: | 77582 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.06 - 5.68) | Buy |
| Bollinger Bands (100): | (4.17 - 6.13) | Buy |
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.14 | Buy |
| Relative Strength Index (14 RSI): | 56.17 | Buy |
| Chaikin Money Flow: | 32814 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (120.38 - 133.94) | Buy |
| Bollinger Bands (100): | (112.94 - 133.06) | Buy |
CAPR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.49 | Buy |
| 20-day SMA: | 5.34 | Buy |
| 50-day SMA: | 5.93 | Buy |
| 200-day SMA: | 4.78 | Buy |
| 8-day EMA: | 5.58 | Buy |
| 20-day EMA: | 5.52 | Buy |
| 50-day EMA: | 5.5 | Buy |
| 200-day EMA: | 4.9 | Buy |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 132.21 | Sell |
| 20-day SMA: | 129.68 | Buy |
| 50-day SMA: | 126.38 | Buy |
| 200-day SMA: | 113.51 | Buy |
| 8-day EMA: | 132.04 | Sell |
| 20-day EMA: | 130.13 | Buy |
| 50-day EMA: | 126.92 | Buy |
| 200-day EMA: | 118.24 | Buy |
Capricor Therapeutics Earnings Growth & CAPR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.07 per share, an increase next quarter of $0.03 per share, a decrease this year of $0.16 per share, and an increase next year of $0.74 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.06 per share, an increase next quarter of $1.31 per share, an increase this year of $6.16 per share, and an increase next year of $6.09 per share.
Capricor Therapeutics Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Sarepta Therapeutics Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||